Interferon γ assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration

Rheumatology International

Volumn 27, Issue 12, 2007, Pages 1143-1148

  Takahashi, Hiroki ^a   Shigehara, Katsunori ^a,b   Yamamoto, Motohisa ^a   Suzuki, Chisako ^a   Naishiro, Yasuyoshi ^a   Tamura, Yasunori ^a   Hirohashi, Yoshihiko ^a   Satoh, Noriyuki ^a   Shijubo, Noriharu ^b   Shinomura, Yasuhisa ^a   Imai, Kohzoh ^c  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sapporo General Hospital of Hokkaido Railway Company   (Japan)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Infliximab; Interferon assay; Latent tuberculosis infection; Rheumatoid arthritis; Tuberculin skin test

Indexed keywords

CYCLOSPORIN; GAMMA INTERFERON; INFLIXIMAB; ISONIAZID; METHOTREXATE; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; MEDICAL RECORD; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; DRUG MONITORING; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTERFERON TYPE II; MALE; METHOTREXATE; MIDDLE AGED; PREDNISOLONE; REPRODUCIBILITY OF RESULTS; TUBERCULIN TEST; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548504312     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-007-0361-2     Document Type: Article

References (17)

1. Hochberg MC, Lebwohl MG, Pelvy SE (2005) sThe benefit/risk profile of TNF-blocking agents: findings of a concensus panel. Semin Arthritis Rheum 34:819-836
2. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM (2001) Tuberculosis associated with infliximab, a tumor necrosis factor a-neutralizing agent. N Engl J Med 345:1098-1104
3. Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk. Arthritis Rheum 48:2122-2127
4. Jasmer RM, Nahid P, Hopewell PC (2002) Latent tuberculosis infection. N Engl J Med 347:1860-1866
5. Tissot F, Zanetti G, Francioli P, Zellweger JP, Zysset F (2005) Influence of Bacilli Calmette-Guerin vaccination on size of tuberculin skin test reaction: to what size? Clin Infect Dis 40:211-217
6. Richeldi L (2006) An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med : [Epub ahead of print]
7. Ferrara G, Losi M, D'Amico R, Roversi P, Piro R, Meacci M, Meccugni B, Dori IM, Andreani A, Bergamini BM, Mussini C, Rumpianesi F, Fabbri LM, Richeldi L (2006) Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367:1328-1334
8. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sakaki Y, Mazurek GH, Tsuyuguchi I (2004) Specific detection of tuberculosis infection. An interferon-γ-based assay using new antigens. Am J Respir Crit Care Med 170:59-64
9. Miyasaka N, Takeuchi T, Eguchi K (2006) Guidelines for the proper use of eternercept in Japan. Mod Rheumatol 16:63-67
10. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A (2005) Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 54:49-55
11. CDC (2005) Guidelines for the investigation of contacts of persons with infectious tuberculosis. MMWR Recomm Rep 54:1-37
12. Brock I, Weldingh K, Lillebaek T, Follmann F, Anderson P (2004) Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 170:65-69
13. Pai M, Riley LW, Colford MC (2004) Interferon-γ assay in the immunodiagnosis of tuberculosis: a systemic review. Lancet Infect Dis 4:761-776
14. Gardam MA, Keystone EC, Menzies R, Manners S, Skamene E, Long R, Vinh DC (2003) Anti-tumor necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3:148-155
15. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P (2006) Latent tuberculosis in HIV positive, diagnosed by the M. Tuberculosis specific interferon gamma test. Respir Res 7:56
16. Connell TG, Curtis N, Ranganathan SC, Buttery JP (2006) Performance of a whole blood interferon gamma assay in detecting latent infection with Mycobacterium tuberculosis in children. Thorax 61:616-620
17. Dheda K, Udwadia ZF, Huggett JF, Johnson MA, Rook GAW (2005) Utility of the antigen-specific interferon-g assay for the management of tuberculosis. Curr Opin Pulm Med 11:195-202